Still a role for second-line chemoimmunotherapy in chronic lymphocytic leukemia?

by Jennifer R Brown
Published 2018-07-01

Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”

by Jennifer R. Brown
Published 2021-11-01

PI3K inhibitors in chronic lymphocytic leukemia: where do we go from here?

by Sigrid S. Skånland, Jennifer R. Brown
Published 2022-07-01

Targeting Bruton’s Tyrosine Kinase in CLL

by Inhye E. Ahn, Jennifer R. Brown
Published 2021-06-01

Assaying and Classifying T Cell Function by Cell Morphology

by Xin Wang, Stacey M. Fernandes, Jennifer R. Brown, Lance C. Kam
Published 2024-04-01

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet?

by Alexey V. Danilov, John M. Pagel, Jennifer R. Brown, Brian T. Hill
Published 2019-08-01

Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors

by C. I. Edvard Smith, Jennifer R. Brown, Rula Zain, Rula Zain
Published 2021-11-01

Editorial: Targeting Bruton Tyrosine Kinase

by Cornelia Brunner, Annika C. Betzler, Jennifer R. Brown, Amy H. Andreotti, Emanuela Grassilli
Published 2022-04-01

Multi-Factor Clustering Incorporating Cell Motility Predicts T Cell Expansion Potential

by Joanne H. Lee, Shuai Shao, Michelle Kim, Stacey M. Fernandes, Jennifer R. Brown, Lance C. Kam
Published 2021-04-01

4321 Personalization of T cell production for cellular immunotherapy

by Dennis Jinglun Yuan, Shuai Shao, Joanne H Lee, Stacey M Fernandes, Jennifer R Brown, Lance C Kam
Published 2020-06-01

The phase III DUO trial of PI3K inhibitor duvelisib versus ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overa...

by Alexey V. Danilov, Ian W. Flinn, Matthew S. Davids, Beth Gregory, Ohad Bentur, David Sidransky, Jennifer R. Brown
Published 2024-05-01

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice

by Susan M. O’Brien, Jennifer R. Brown, John C. Byrd, Richard R. Furman, Paolo Ghia, Jeff P. Sharman, William G. Wierda
Published 2021-11-01

Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target

by Carlos Cuesta-Mateos, Carlos Cuesta-Mateos, Carlos Cuesta-Mateos, Jennifer R. Brown, Fernando Terrón, Fernando Terrón, Cecilia Muñoz-Calleja, Cecilia Muñoz-Calleja
Published 2021-03-01

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)

by Barbara Eichhorst, Nicole Lamanna, Susan O’brien, Constantine Tam, Lugui Qiu, Keri Yang, Ken Wu, Tommi Salmi, Gisoo Barnes, Jennifer R. Brown
Published 2023-08-01

Recrystallization inhibition in ice due to ice binding protein activity detected by nuclear magnetic resonance

by Jennifer R. Brown, Joseph D. Seymour, Timothy I. Brox, Mark L. Skidmore, Chen Wang, Brent C. Christner, Bing-Hao Luo, Sarah L. Codd
Published 2014-09-01

Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells.

by Cody Paiva, J Claire Godbersen, Ryan S Soderquist, Taylor Rowland, Sumner Kilmarx, Stephen E Spurgeon, Jennifer R Brown, Sreesha P Srinivasa, Alexey V Danilov
Published 2015-01-01

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

by Davide Rossi, Mazyar Shadman, Adalgisa Condoluci, Jennifer R. Brown, John C. Byrd, Gianluca Gaidano, Michael Hallek, Peter Hillmen, Anthony Mato, Emili Montserrat, Paolo Ghia
Published 2020-08-01

MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells.

by Shuqiang Li, Howell F Moffett, Jun Lu, Lillian Werner, Hao Zhang, Jerome Ritz, Donna Neuberg, Kai W Wucherpfennig, Jennifer R Brown, Carl D Novina
Published 2011-03-01

Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies

by Katrine Melvold, Mariaserena Giliberto, Linda Karlsen, Pilar Ayuda‐Durán, Robert Hanes, Toril Holien, Jorrit Enserink, Jennifer R. Brown, Geir E. Tjønnfjord, Kjetil Taskén, Sigrid S. Skånland
Published 2022-03-01

P644: IBRUTINIB DOSE MODIFICATIONS FOR MANAGEMENT OF CARDIAC ADVERSE EVENTS IN PATIENTS WITH B-CELL MALIGNANCIES: POOLED ANALYSIS OF 10 CLINICAL TRIALS

by Deborah Stephens, Jennifer R. Brown, Shuo MA, Michael Wang, Carol Moreno, Tadeusz Robak, Don Stevens, Shane Lee, Chadi Saifan, Emily Hsu, Sima Patel, Jan Burger
Published 2023-08-01